Chagas disease in the Netherlands: An estimate of the number of patients;De ziekte van chagas in Nederland: Een schatting van het aantal patiënten

Nederlands Tijdschrift voor Geneeskunde

Volumn 155, Issue 19, 2011, Pages 878-884

  Bart, Aldert ^a   Hodiamont, Caspar J ^a   Grobusch, Martin P ^a   Van Den Brink, Renée B A ^a   Smout, André J P M ^a   Van Gool, Tom ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHAGAS DISEASE; INCIDENCE; NETHERLANDS;

EID: 79957581037     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388-402.
2. World Health Organization. Control and prevention of Chagas disease in Europe. Genève: WHO; 2010.
3. Jackson Y, Getaz L, Wolff H, et al. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis. 2010;4:e592.
4. Organización Panamericana de la Salud. Estimación cuantitativa de la enfermedad de Chagas en las Américas. Montevideo, Uruguay: Organización Panamericana de la Salud OPS/HDM/CD/425-06; 2006.
5. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA. 2007;298:2171-81. (Pubitemid 350106656)
6. Martínez S, Restrepo CS, Carrillo JA, et al. Thoracic Manifestations of Tropical Parasitic Infections: A Pictorial Review. RadioGraphics. 2005;25:135-55 . (Pubitemid 40186946)
7. Maguire JH, Hoff R, Sherlock I, et al. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation. 1987;75:1140-5. (Pubitemid 17081020)
8. Rassi A Jr, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006;355:799-808. (Pubitemid 44285585)
9. Yacoub S, Mocumbi AO, Yacoub MH. Neglected tropical cardiomyopathies: I. Chagas disease: myocardial disease. Heart. 2008;94:244-8.
10. de Oliveira RB, Troncon LE, Dantas RO, Menghelli UG. Gastrointestinal manifestations of Chagas' disease. Am J Gastroenterol. 1998;93:884-9.
11. Marcu CB, Beek AM, Van Rossum AC. Chagas' heart disease diagnosed on MRI: the importance of patient 'geographic' history. Int J Cardiol. 2007;117:e58-60.
12. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14-21.
13. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010;115:22-7.
14. Guerri-Guttenberg RA, Grana DR, Ambrosio G, Milei J. Chagas cardiomyopathy: Europe is not spared! Eur Heart J. 2008;29:2587-91.
15. Rawlins SC, Baboolal S, Parsad K, et al. The prevalence of antibodies to Trypanosoma cruzi in Guyana, Suriname and Trinidad & Tobago. Surinam Medical Bulletin. 2001;16:25-40.
16. Oostburg BF, Anijs JE, Oehlers GP, Hiwat HO, Burke-Hermelijn SM. Case report: the first parasitologically confirmed autochthonous case of acute Chagas disease in Suriname. Trans R Soc Trop Med Hyg. 2003;97:166-7. (Pubitemid 37265626)
17. Aznar C, La RG, Laventure S, Carme B, Liegeard P, Hontebeyrie M. Seroprevalence of Trypanosoma cruzi infection in French Guiana. Mem Inst Oswaldo Cruz. 2004;99:805-8. (Pubitemid 40248976)
18. WHO Expert Committee on the Control of Chagas Disease. Control of Chagas disease: second report of the WHO expert committee. WHO technical report series, nr. 905. Genève: WHO; 2002.
19. Urbina JA. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop. 2010;115:55-68.
20. Lescure FX, Le LG, Freilij H, et al. Chagas disease: changes in knowledge and management. Lancet Infect Dis. 2010;10:556-570.
21. Pérez-Molina JA, Perez-Ayala A, Moreno S, Fernandez-Gonzalez MC, Zamora J, Lopez-Velez R. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. J Antimicrob Chemother. 2009;64:1139-47.
22. Villar JC, Marin-Neto JA, Ebrahim S, Yusuf S. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst Rev. 2002;CD003463.
23. Marin-Neto JA, Rassi A Jr, Morillo CA, et al. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J. 2008;156:37-43. (Pubitemid 351862295)